A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults - Trial NCT06243835
Access comprehensive clinical trial information for NCT06243835 through Pure Global AI's free database. This Phase 1 trial is sponsored by Lohocla Research Corporation and is currently Not yet recruiting. The study focuses on Chronic Pain. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Lohocla Research Corporation
Timeline & Enrollment
Phase 1
Apr 01, 2024
Nov 30, 2024
Primary Outcome
Incidence, Severity and Relationship of Adverse Events [Safety and Tolerability]
Summary
The goal of this study is to test Kindolor in healthy adults. The main questions it aims to
 answer are:
 
 - What is the safe dose of Kindolor in healthy volunteers?
 
 - How is Kindolor metabolized by the human body?
 
 Participants will undergo medical tests before and after receiving Kindolor or a placebo to
 see if there is any difference between the groups.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06243835
Non-Device Trial